Download Files:
HL23
Price range: 2,192 CAD through 5,920 CAD
Products Details
Product Description
– HL23 is a histone deacetylase (HDAC) inhibitor that effectively targets hepatocellular carcinoma (HCC). It promotes acetylation at the TXNIP promoter and increases TXNIP expression, modulating potassium channel activity and inducing TXNIP-dependent potassium deficiency. Additionally, HL23 impedes HCC progression and spread, demonstrating greater potency when combined with Sorafenib than the Sorafenib and Vorinostat duo [1].
Web ID
– T79407
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C44H44N2O7
CAS Number
– 1448355-15-4
Molecular Weight
– C44H44N2O7
SMILES
– O(C(=O)C1=CC=CC=C1)C2=C3C=4[C@](CC=5C=C(C(OC)=CC5)OC=6C=CC(C[C@]7(C8=CC(O3)=C(OC)C=C8CCN7C)[H])=CC6)(N(C)CCC4C=C2OC)[H]
Pathway
– Others
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock
